Table 2.
Characteristics of the included trial
| Author | Year of publication | Disease | Subject (age: Mean + SD) | Intervention methods | Intervention Period | Intervention time | Outcomes |
|---|---|---|---|---|---|---|---|
| Alkatan et al | 2016 | Osteoarthritis | 40 subjects | AE + LE | 12 weeks [3/week] | AE:20–45'Intervention LE:20–45'Intervention | Pain; physical function; quality of life |
| AE(N = 20) | |||||||
| LE(N = 20) | |||||||
| Andrade et al | 2018 | Fibromyalgia | 54 F AE(N = 27) 48 ± 8 NE(N = 27) 47 ± 8 | AE + NE | 16 weeks [2/week] | AE: 45'Intervention | Pain; physical function; quality of life |
| Assis et al | 2006 | Fibromyalgia | 60 F AE(N = 30) 43.43 ± 10.76 LE(N = 30) 42.17 ± 10.05 | AE + LE | 15 weeks [3/week] | AE:10'W + 40 MW + 10'Str LE:10'W + 40 MW + 10'Str | physical function; quality of life |
| Baena-Beato et al | 2014 | Low back pain | 38 subjects AE(N = 21) 50.9 ± 9.6 12F + 9 M NE(N = 17) 46.2 ± 9.8 10F + 7 M | AE + NE | 2 months [5/week] | AE:10'W + 35–45'MW + 10'str | Pain; physical function; quality of life |
| Belza et al | 2002 | Osteoarthritis | 157 subjects AE(N = 36) NE(N = 121) | AE + NE | 20 weeks [2/week] | AE: 1 h Intervention | Pain; quality of life |
| Britto et al | 2020 | Fibromyalgia | 33 F AE(N = 16) 50.25 ± 6.09 LE(N = 17) 46.18 ± 10.84 | AE + LE | 8 weeks [3/week] | AE:10'W + 40'MW + 10'Str LE:10'w + 40'MW + 10'Str | Pain; physical function; quality of life |
| Cuesta-Vargas et al | 2012 | Low back pain | 49 subjects AE(N = 25) NE(N = 24) | AE + NE | 16 weeks [3/week] | AE:30'Intervention | Pain; physical function |
| Dundar et al | 2009 | Low back pain | 65 subjects AE(N = 32) 35.3 ± 7.8 LE(N = 33) 34.8 ± 8.3 | AE + LE | 4 weeks [5/week] | AE:15'W + 40 MW + 5'Str LE:60'Intervention | Pain; physical function |
| Dundar et al | 2014 | Ankylosing spondylitis | 69 subjects AE(N = 35) 42.3 ± 11.3 5F + 30 M LE(N = 34) 43.1 ± 11.7 6F + 28 M | AE + LE | 4 weeks [5/week] | AE:15'W + 40 MW + 5'Str LE:60'Intervention | Pain; physical function |
| Evcik et al | 2008 | Fibromyalgia | 61 subjects AE(N = 31) 43.8 ± 7.7 LE(N = 30) 42.8 ± 7.6 | AE + LE | 5 weeks [3/week] | AE:20'W + 35 MW + 5'Str LE:60'Intervention | Pain |
| Fonseca et al | 2019 | Fibromyalgia | 46 F AE(N = 27) 53.78 ± 10.40 LE(N = 19) 54.47 ± 11.18 | AE + LE | 10 weeks[1/week] | AE:5'W + 45'MW + 10'Str LE:45'MW | Pain; quality of life |
| Fransen et al | 2007 | Osteoarthritis | 96 subjects AE(N = 55) 70.0 ± 6.3 40F + 15 M NE(N = 41) 69.6 ± 6.1 34F + 7 M | AE + NE | 12 weeks [2/week] | AE:60'Intervention | Pain; physical function |
| Guillemin et al | 1994 | Low back pain | 102 subjects AE(N = 50) NE(N = 52) | AE + NE | 3 weeks | AE:15'Intervention | Pain; quality of life |
| Gusi et al | 2006 | Fibromyalgia | 34 F AE(N = 17) 51 ± 10 NE(N = 17) 51 ± 9 | AE + NE | 12 weeks [3/week] | AE:10'W + 40 MW + 10'Str | Pain; quality of life |
| Hale et al | 2011 | Osteoarthritis | 35 subjects AE(N = 20) NE(N = 15) | AE + NE | 12 weeks [2/week] | AE:20'-60'Intervention | Pain; physical function; quality of life |
| Hinman et al | 2007 | Osteoarthritis | 71 subjects AE(N = 36) 63.3 ± 9.5 24F + 12 M NE(N = 35) 61.5 ± 7.8 24F + 11 M | AE + NE | 6 weeks [2/week] | AE:45'-60'Intervention | Pain; physical function; quality of life |
| Lim et al | 2010 | Osteoarthritis | 75 subjects AE(N = 26) 65.7 ± 8.9 23F + 3 M LE(N = 25) 67.7 ± 7.7 21F + 4 M NE(N = 24) 63.6 ± 5.3 21F + 3 M | AE + LE + NE | 8 weeks [3/week] | AE:5'W + 30 MW + 5'Str LE:5'W + 30 MW + 5'Str | Pain; physical function |
| Lund et al | 2008 | Osteoarthritis | 79 subjects AE(N = 27) 65 ± 12.6 22F + 5 M LE(N = 25) 68 ± 9.5 20F + 5 M NE(N = 27) 70 ± 9.9 20F + 7 M | AE + LE + NE | 8 weeks [2/week] | AE:10'W + 30'MW + 10'Str LE:10'W + 30'MW + 10'Str | Pain; quality of life |
| Mannerkorpi et al | 2009 | Fibromyalgia | 166 F AE(N = 81) 44.6 ± 9.26 NE(N = 85) 46.5 ± 8.30 | AE + NE | 20 weeks [1/week] | AE:45'Intervention | Pain; physical function; quality of life |
| McIlroy et al | 2017 | Osteoarthritis | 13 F AE(N = 7) 64.3 ± 8.7 NE(N = 6) 62.3 ± 6.6 | AE + NE | 6 weeks | AE:30'Intervention | Pain; physical function |
| Munguía-Izquierdo et al | 2008 | Fibromyalgia | 58 subjects AE(N = 34) 50 ± 7 NE(N = 24) 46 ± 8 | AE + NE | 16 weeks [3/week] | AE:10'W + 40 MW + 10'Str | Pain; physical function; quality of life |
| Munukka et al | 2016 | Osteoarthritis | 84 F AE(N = 42) 64 ± 2 NE(N = 42) 64 ± 2 | AE + NE | 16 weeks [3/week] | AE:60'Intervention | Pain; quality of life |
| Patrick et al | 2001 | Osteoarthritis | 249 subjects AE(N = 125) 65.7 109F + 16 M NE(N = 124) 66.1 106F + 18 M | AE + NE | 20 weeks [2/week] | AE:45–60'Intervention | Pain; quality of life |
| Sahin et al | 2018 | Osteoarthritis | 59 F AE(N = 30) 60.46 ± 6.82 | NE(N = 29) 58.23 ± 7.55 | AE + NE 3 weeks [5/week] | AE:45'-60'W | Quality of life |
| Silva et al | 2008 | Osteoarthritis | 64 subjects AE(N = 32) 59 ± 7.60 30F + 2 M | LE(N = 32) 59 ± 6.08 29F + 3 M | AE + LE 18 weeks [3/week] | AE:50'Intervention LE:50'Intervention | Pain |
| Sjogren et al | 1997 | Low back pain | 56 subjects AE(N = 28) LE(N = 28) | AE + LE | 6 weeks [2/week] | AE:50'Intervention LE:50'Intervention | Pain; physical function |
| Taglietti et al | 2018 | Osteoarthritis | 60 subjects AE(N = 31) 67.3 ± 5.9 8 M + 23F NE(N = 29) 68.7 ± 6.7 11 M + 18F | AE + NE | 8 weeks [2/week] | AE:60'Intervention | Pain; physical function; quality of life |
| Tomas-Carus et al | 2007 | Fibromyalgia | 34 F AE(N = 17) 51 ± 10 NE(N = 17) 51 ± 9 | AE + NE | 12 weeks [3/week] | AE: 10'W + 40'MW + 10'Str | Pain; physical function; quality of life |
| Tomas-Carus et al | 2008 | Fibromyalgia | 30 F AE(N = 15) 50.7 ± 10.6 NE(N = 15) 50.9 ± 6.7 | AE + NE | 8 months [3/week] | AE:10'w + 50'Intervention | Pain; physical function; quality of life |
| Tomas-Carus et al | 2009 | Fibromyalgia | 30 F AE(N = 15) 50.7 ± 10.6 NE(N = 15) 50.9 ± 6.7 | AE + NE | 32 weeks [3/week] | AE:10'W + 50'MW | Pain; physical function |
| Waller et al | 2017 | osteoarthritis | 87 F AE(N = 43) 63.8 ± 2.4 NE(N = 44) 63.9 ± 2.4 | AE + NE | 16 weeks [3/week] | AE: 60'Intervention | Pain; quality of life |
| Wang et al | 2010 | Osteoarthritis | 78 subjects AE(N = 26) 66.7 ± 5.6 22F + 4 M LE(N = 26) 68.3 ± 6.4 23F + 3 M NE(N = 26) 67.9 ± 5.9 22F + 4 M | AE + LE + NE | 12 weeks [3/week] | AE:5'W + 40 MW + 5'Str LE:5'W + 40 MW + 5'Str | Pain; quality of life |